Nuzenio

Ractigen Therapeutics Announces

Ractigen Therapeutics Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:56:14 GMT FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy - Ophthalmology Times EuropeOphthalmology Times Europe · Mon, 03 Aug 2026 19:02:58 GMT Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy - The Manila TimesThe Manila Times · Fri, 31 Jul 2026 11:26:59 GMT miRecule and Rio Biofarma to develop RNA therapeutic delivery technologies - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT Ractigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 11:56:14 GMTRactigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila Times

Mon, 03 Aug 2026 19:02:58 GMTFDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy - Ophthalmology Times Europe

Fri, 31 Jul 2026 11:26:59 GMTRactigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy - The Manila Times

Fri, 31 Jul 2026 07:00:00 GMTmiRecule and Rio Biofarma to develop RNA therapeutic delivery technologies - Yahoo Finance

Wed, 29 Jul 2026 07:00:00 GMTRactigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms - Yahoo Finance

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

RAG4 live mentions The Manila Times4 live mentions Ophthalmology Times Europe3 live mentions Completion2 live mentions Enrollment2 live mentions First Dosing2 live mentions Phase II Clinical2 live mentions Trial2 live mentions FDA Clears IND2 live mentions FDA IND Clearance2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ractigen Therapeutics Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.